Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | thymidylate synthase | 0.2079 | 0.9393 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0122 | 0.0174 | 0.0185 |
Onchocerca volvulus | 0.2079 | 0.9393 | 0.5 | |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.2208 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0989 | 0.4257 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.2079 | 0.9393 | 1 |
Brugia malayi | hypothetical protein | 0.0989 | 0.4257 | 0.3744 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0337 | 0.1183 | 0.1095 |
Schistosoma mansoni | dihydrofolate reductase | 0.0337 | 0.1183 | 0.126 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.2079 | 0.9393 | 1 |
Echinococcus granulosus | thymidylate synthase | 0.2079 | 0.9393 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.2208 | 1 | 0.5 |
Echinococcus multilocularis | thymidylate synthase | 0.2079 | 0.9393 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.2079 | 0.9393 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.2208 | 1 | 0.5 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0337 | 0.1183 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.2208 | 1 | 0.5 |
Echinococcus granulosus | dihydrofolate reductase | 0.0337 | 0.1183 | 0.1095 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.2208 | 1 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0989 | 0.4257 | 0.3744 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.2079 | 0.9393 | 1 |
Brugia malayi | thymidylate synthase | 0.2079 | 0.9393 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 56 % | In vitro functional activity on the isolated guinea pig gallbladder | ChEMBL. | 8978852 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.